These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
755 related articles for article (PubMed ID: 9134653)
1. Pretreatment of human platelets with plasmin inhibits responses to thrombin, but potentiates responses to low concentrations of aggregating agents, including the thrombin receptor activating peptide, SFLLRN. Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA Thromb Haemost; 1997 Apr; 77(4):741-7. PubMed ID: 9134653 [TBL] [Abstract][Full Text] [Related]
2. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression. Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947 [TBL] [Abstract][Full Text] [Related]
4. Contrasting effects of thrombin and the thrombin receptor peptide, SFLLRN, on aggregation and release of 14C-serotonin by human platelets pretreated with chymotrypsin or serratia marcescens protease. Kinlough-Rathbone RL; Perry DW; Packham MA Thromb Haemost; 1995 Jan; 73(1):122-5. PubMed ID: 7740483 [TBL] [Abstract][Full Text] [Related]
5. Effects of tris on responses of human and rabbit platelets to aggregating agents. Packham MA; Guccione MA; Nina M; Kinlough-Rathbone RL; Mustard JF Thromb Haemost; 1984 Apr; 51(2):140-4. PubMed ID: 6429880 [TBL] [Abstract][Full Text] [Related]
6. Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents. Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA Thromb Res; 1999 Sep; 95(6):315-23. PubMed ID: 10527409 [TBL] [Abstract][Full Text] [Related]
7. Characteristics of thrombin-degranulated human platelets: development of a method that does not use proteolytic enzymes for deaggregation. Kinlough-Rathbone RL; Packham MA; Guccione MA; Richardson M; Harfenist EJ; Mustard JF Thromb Haemost; 1991 Apr; 65(4):403-10. PubMed ID: 2057923 [TBL] [Abstract][Full Text] [Related]
8. Degranulation of human platelets by the thrombin receptor peptide SFLLRN: comparison with degranulation by thrombin. Kinlough-Rathbone RL; Perry DW; Guccione MA; Rand ML; Packham MA Thromb Haemost; 1993 Dec; 70(6):1019-23. PubMed ID: 8165594 [TBL] [Abstract][Full Text] [Related]
10. Unexpected effects of aurin tricarboxylic acid on human platelets. Kinlough-Rathbone RL; Packham MA Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166 [TBL] [Abstract][Full Text] [Related]
11. Probenecid inhibits platelet responses to aggregating agents in vitro and has a synergistic inhibitory effect with penicillin G. Packham MA; Rand ML; Perry DW; Ruben DH; Kinlough-Rathbone RL Thromb Haemost; 1996 Aug; 76(2):239-44. PubMed ID: 8865538 [TBL] [Abstract][Full Text] [Related]
12. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes. Winocour PD; Kinlough-Rathbone RL; Mustard JF J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538 [TBL] [Abstract][Full Text] [Related]
13. Effect of the concentration of Ca2+ in the suspending medium on the responses of human and rabbit platelets to aggregating agents. Packham MA; Bryant NL; Guccione MA; Kinlough-Rathbone RL; Mustard JF Thromb Haemost; 1989 Nov; 62(3):968-76. PubMed ID: 2512683 [TBL] [Abstract][Full Text] [Related]
14. Exposure of human platelets to plasmin results in the expression of irreversibly active fibrinogen receptors. Rabhi-Sabile S; Pidard D Thromb Haemost; 1995 Apr; 73(4):693-701. PubMed ID: 7495081 [TBL] [Abstract][Full Text] [Related]
15. Enhanced increases in cytosolic Ca2+ in ADP-stimulated platelets from patients with delta-storage pool deficiency--a possible indicator of interactions between granule-bound ADP and the membrane ADP receptor. Lages B; Weiss HJ Thromb Haemost; 1997 Feb; 77(2):376-82. PubMed ID: 9157599 [TBL] [Abstract][Full Text] [Related]
16. Effects of thrombin and the thrombin receptor activating peptide, SFLLRN, on redistribution of platelet alpha-granule contents are similar and independent of the extent of thromboxane formation. Suzuki H; Packham MA; Kinlough-Rathbone RL Exp Mol Pathol; 1995 Feb; 62(1):63-72. PubMed ID: 7556592 [TBL] [Abstract][Full Text] [Related]
17. Functional characterization of PM6/13, a beta3-specific (GPIIIa/CD61) monoclonal antibody that shows preferential inhibition of fibrinogen binding over fibronectin binding to activated human platelets. Patel Y; Rahman S; Siddiqua A; Wilkinson JM; Kakkar VV; Authi KS Thromb Haemost; 1998 Jan; 79(1):177-85. PubMed ID: 9459345 [TBL] [Abstract][Full Text] [Related]
18. Effect of amino sugars on platelet aggregation and on fibrinogen binding. Kinlough-Rathbone RL; Packham MA; Mustard JF Thromb Haemost; 1984 Aug; 52(1):75-80. PubMed ID: 6495268 [TBL] [Abstract][Full Text] [Related]
19. Thrombin receptor-activating peptide releases arachidonic acid from human platelets: a comparison with thrombin and trypsin. McNicol A; Robson CA J Pharmacol Exp Ther; 1997 May; 281(2):861-7. PubMed ID: 9152395 [TBL] [Abstract][Full Text] [Related]